Cargando…
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Reports of COVID-19-associated mucormycosis have been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes and hyperglycaemia often have an inflammatory state that could be potentiated by the activation of antiviral immunity to SARS...
Autores principales: | Hoenigl, Martin, Seidel, Danila, Carvalho, Agostinho, Rudramurthy, Shivaprakash M, Arastehfar, Amir, Gangneux, Jean-Pierre, Nasir, Nosheen, Bonifaz, Alexandro, Araiza, Javier, Klimko, Nikolai, Serris, Alexandra, Lagrou, Katrien, Meis, Jacques F, Cornely, Oliver A, Perfect, John R, White, P Lewis, Chakrabarti, Arunaloke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789240/ https://www.ncbi.nlm.nih.gov/pubmed/35098179 http://dx.doi.org/10.1016/S2666-5247(21)00237-8 |
Ejemplares similares
-
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
por: Muthu, Valliappan, et al.
Publicado: (2021) -
Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis
por: Prakash, Hariprasath, et al.
Publicado: (2021) -
Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients
por: Ghosh, Anup K., et al.
Publicado: (2022) -
P407 Standardization of PCR for the diagnosis of invasive aspergillosis and invasive mucormycosis from blood samples
por: Rompally, Satwika, et al.
Publicado: (2022) -
Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2019)